Literature DB >> 17322912

From Tpr-Met to Met, tumorigenesis and tubes.

P Peschard1, M Park.   

Abstract

The receptor for hepatocyte growth factor (HGF)/scatter factor (SF), Met, controls a program of invasive epithelial growth through the coordination of cell proliferation and survival, cell migration and epithelial morphogenesis. This process is important during embryogenesis and for organ regeneration in the adult. However, when deregulated the HGF/SF-Met signaling axis contributes to tumorigenesis and metastasis. Studies on the oncogenic activation of the Met receptor have shed light on the molecular mechanisms underlying the oncogenic activation of receptor tyrosine kinase (RTKs). More than a decade ago, work on the Met related oncogene, Tpr-Met, revealed the mechanism for activation of RTK-derived oncogenes generated following chromosomal translocation. More recently, studies on the mechanisms of downregulation of the Met RTK highlight a role for loss of downregulation in RTK oncogenic activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322912     DOI: 10.1038/sj.onc.1210201

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  76 in total

1.  Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.

Authors:  Katharine D Grugan; Charles G Miller; Yao Yao; Carmen Z Michaylira; Shinya Ohashi; Andres J Klein-Szanto; J Alan Diehl; Meenhard Herlyn; May Han; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  The transcription factors Etv4 and Etv5 mediate formation of the ureteric bud tip domain during kidney development.

Authors:  Satu Kuure; Xuan Chi; Benson Lu; Frank Costantini
Journal:  Development       Date:  2010-05-12       Impact factor: 6.868

3.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

4.  PTP1B targets the endosomal sorting machinery: dephosphorylation of regulatory sites on the endosomal sorting complex required for transport component STAM2.

Authors:  Matthew Stuible; Jasmine V Abella; Matthew Feldhammer; Misha Nossov; Veena Sangwan; Blagoy Blagoev; Morag Park; Michel L Tremblay
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

5.  Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

Authors:  Y Gui; M Yeganeh; Y-C Donates; W-S Tobelaim; W Chababi; M Mayhue; A Yoshimura; S Ramanathan; C Saucier; S Ilangumaran
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

Review 6.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 7.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.

Authors:  Yiru Xu; Jin Zhou; Thomas E Carey; Jonathan B McHugh; John J Voorhees; Gary J Fisher
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

9.  Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.

Authors:  Veena Sangwan; Grigorios N Paliouras; Jasmine V Abella; Nadia Dubé; Anie Monast; Michel L Tremblay; Morag Park
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

Review 10.  The multiple paths towards MET receptor addiction in cancer.

Authors:  Leslie Duplaquet; Zoulika Kherrouche; Simon Baldacci; Philippe Jamme; Alexis B Cortot; Marie-Christine Copin; David Tulasne
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.